MedPath
TGA Approval

DBL Bortezomib bortezomib 1.0 mg powder for injection vial (313359)

313359

DBL Bortezomib bortezomib 1.0 mg powder for injection vial

Pfizer Australia Pty Ltd

February 10, 2020

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/fe875102a8261a47370231d511f3e10b.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/8e2954d456fbe3e35ad4acde905ef547.pdf

Active Ingredients

bortezomib

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DBL Bortezomib bortezomib 1.0 mg powder for injection vial (313359) - TGA 批准文号 | MedPath